GZS-411ГЗС-411
A synthetic dimeric dipeptide designed to mimic loop 1 of neurotrophin-4, a nerve-cell signaling protein. The reported experiments measured cellular responses.
What the studies found
Lab research · 2026
N-Isocaproyl-L-Arginylglycine Hexamethylenediamide, First Low-Molecular-Weight Mimetic of Neurotrophin-4: Design and Neuroprotective Activity.
GZS-411 activated TrkB and protected cultured cells against oxidative stress, glutamate toxicity and 6-hydroxydopamine. The study does not establish animal or human treatment effects.
Study notes · methods, sources and limitations
Participants or model Mouse HT-22 and human SH-SY5Y cell lines
Important limitations
- Preclinical findings do not establish human benefit or safety. Abstract only. Full methods and independent replication remain unconfirmed.
Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections · Indexed abstract
About GZS-411
Names in this research collection
NT-4 · Neurotrophin-4 · N-isocaproyl-L-arginylglycine hexamethylenediamide
Research background
A 2026 experimental dimeric dipeptide designed from NT-4 loop 1. Its currently linked findings are cell-based.
- Compound class
- Experimental peptide
- Research collection
- Neuropeptide research · editorial grouping
- Institutions in linked studies
- See individual study records
- Source review
- Review dates and the material assessed are listed with each publication below.
Understanding the evidence
Human research
No human treatment trial assessed for this family
Study methods
Member-specific studies; patents and archival leads identified separately
Independent replication
Independent replication not established by the records collected here
Source access
Primary abstracts, selected full texts, patents and explicit retrieval targets
Safety evidence
Cell and animal effects do not establish human safety; analogues may differ
Open a topic for the evidence assessment.
Findings by study
Lab research · 2026
N-Isocaproyl-L-Arginylglycine Hexamethylenediamide, First Low-Molecular-Weight Mimetic of Neurotrophin-4: Design and Neuroprotective Activity.
GZS-411 activated TrkB and protected cultured cells against oxidative stress, glutamate toxicity and 6-hydroxydopamine. The study does not establish animal or human treatment effects.
Study notes and original source
N-Isocaproyl-L-Arginylglycine Hexamethylenediamide, First Low-Molecular-Weight Mimetic of Neurotrophin-4: Design and Neuroprotective Activity.
Gudasheva TA, Sokolenko NI, Kolyasnikova KN, Antipova TA, Zainullina LF, Sergeeva MS, Dorofeev VL · Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections
GZS-411 activated TrkB and protected cultured cells against oxidative stress, glutamate toxicity and 6-hydroxydopamine. The study does not establish animal or human treatment effects.
- Population / setting
- Mouse HT-22 and human SH-SY5Y cell lines
- Source reviewed
- Primary publication metadata and indexed abstract checked via Europe PMC; full methodological review pending.
Study limitations
- Preclinical findings do not establish human benefit or safety.
- Abstract only. Full methods and independent replication remain unconfirmed.
Reviewed 2026-10-05.
Research collection curated by @PepMariner · editorial standards. Send a source correction ↗
Browse bibliography & PDFs ↗